Navigation Links
Neck Fat a Measure of Heart Risk
Date:3/11/2009

It signals danger independently of stomach fat, researchers report

WEDNESDAY, March 11 (HealthDay News) -- A too-tight shirt collar might be an indicator of future heart trouble, Framingham Heart Study researchers report.

Doctors have long measured fat in the gut -- visceral adipose tissue, to use the formal name -- to help assess the risk of cardiovascular disease. But fat in the neck is closely associated with the known factors for heart trouble, such as cholesterol levels and diabetes, said a report using data on 3,320 offspring of the study's original participants.

"Neck circumference was associated with cardiometabolic risk factors, even after adjustment for visceral adipose tissue," the researchers wrote in the report, which was to be presented Wednesday at the American Heart Association's Cardiovascular Disease Epidemiology and Prevention annual conference in Palm Harbor, Fla.

The standard ways to assess obesity is to measure the waistline and determine body-mass index. But neck fatness could add to the risk assessment a physician makes by measuring the waistline, the researchers said.

"Upper-body subcutaneous adipose tissue and visceral adipose tissue independently contribute to cardiometabolic risk," they reported.

Dr. Gregg C. Fonarow, a professor of medicine at the University of California, Los Angeles, said the researchers had "done a really good job of looking past the conventional measurements of risk."

"This is another way by which clinicians can assess the degree of adiposity of patients as a measure of cardiovascular risk and make recommendations about reducing risk," he said.

But the basic message, Fonarow said, is that carrying too much fat is not good for the heart, no matter where in the body the fat happens to be.

"It is just another insight into how much adipose tissue there is," he said. "When you measure waist circumference, you look at visceral fat in the abdomen. Here you're looking at visceral fat in another area of the body."

"The study makes good sense to me," said Dr. Kirk Garratt, director of interventional cardiovascular research at Lenox Hill Hospital in New York City. "They are putting a quantifiable measurement on something we've known for some time -- that people with upper-body obesity are at heightened risk of cardiovascular disease."

The obese body comes in two forms, Garratt said: pear-shaped, with most of the excess weight around the hips; and apple-shaped, with most of the weight in the upper part of the body.

"People with most of the weight in the upper part of the body have more cardiovascular disease," Garratt said. "It appears to be that certain kinds of metabolic abnormalities contribute to the atherothrombotic risk."

But no matter where the excess fat is located, it's best to lose it, he said.

"Everybody who has a body-mass index over 25 increases the risk of coronary events, regardless of where they are carrying their weight," Garratt said.

More information

The American Heart Association has more on the risks of obesity.



SOURCES: Gregg Fonarow, M.D., professor, medicine, University of California, Los Angeles; Kirk Garratt, M.D., clinical director, interventional cardiovascular research, Lenox Hill Hospital, New York City; March 11, 2009, presentation, American Heart Association's Cardiovascular Disease Epidemiology and Prevention annual conference, Palm Harbor, Fla.


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Use of certain lipid measures not more effective in predicting coronary heart disease
2. Wild American Shrimp Board Agrees To Implement New Self-Funding Measures
3. Valley Health System Caregivers, Members of SEIU UHW, to Announce Endorsement of Measure G
4. People overestimate their self-reported sleep times compared to measures by a sleep test
5. Brain measurements could lead to better devices to move injured or artificial limbs
6. PA Health Department Suggests Measures to Reduce the Spread of MRSA
7. New Measures Improve Heart Care
8. New anemia measure predicts risk of death in dialysis patients
9. Nano-sized voltmeter measures electric fields deep within cells
10. New Lancet Study: Tobacco Control Measures Are Effective and Affordable Strategies to Reduce Chronic Disease Deaths Globally
11. AMAS Test Measures Lethal Replikin Gene Activity in Lung and Other Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Neck Fat a Measure of Heart Risk
(Date:4/30/2016)... ... April 30, 2016 , ... ... President and CEO of EMED, today signed a multifaceted agreement which will allow ... the Northern Caribbean University Department of Natural and Applied Sciences, Allied Health and ...
(Date:4/29/2016)... ... 30, 2016 , ... Mercy College is expanding its Graduate Business Programs to ... expanding due to high demand: Master of Business Administration (MBA), Master of Organizational Leadership ... , School of Business Graduate Program Chair Dr. Ray Manganelli said: “We believe ...
(Date:4/29/2016)... ... 29, 2016 , ... Our bodies are bombarded daily by environmental and lifestyle ... these stressors is to adopt a more healthful diet, but too many people think ... certified Holistic Nutritionist and the creator of the Newport Beach Cleanse and 14-Day Eating ...
(Date:4/29/2016)... ... April 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) ... with sunny skies, a light breeze and temperatures in the 60s. Over 400 runners, ... Run and Walk and 1-mile walk were held to increase awareness about Lyme ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Mobility Designed ... put pressure on the armpits, the M+D Crutch evenly distributes body weight from the ... wrists and hands when using the crutches than with other crutches. , Co-founders Max ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... 27, 2016 ... in Zürich gab Strekin AG den Start ... zur Erhaltung des Resthörvermögens von Patienten, denen ... die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan ... wird während der Operation direkt ins Mittelohr ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology: